Behavioural and productive response to experimental infection with stage 3 larvae of Haemonchus contortus in feedlot bull-calves.

Haemonchus contortus is a nematode parasite that establishes in the abomasum of ruminants, it has a cosmopolitan distribution and is a worldwide health problem for livestock. As a first line of defence against parasites, behaviour can help to prevent or fight infection, and may even serve as a method of early presumptive diagnosis. Parasites can affect performance of cattle and cause significant economic losses. The aim of this study was to determine the behavioural and productive changes induced by an experimental infection with H. contortus L3 in bovines. We used 32 dewormed bull calves, randomly divided into two groups, 8 no inoculated controls and 24 that were inoculated with 4000 L3 of H. contortus. Inoculation did not influence haematocrit or haemoglobin values at 0, 28 and 42 days post infection (P> 0.20); however, an increase in the frequency of urination (P = 0.0001) and defecation (P = 0.0001), number of steps (P < 0.001) and self-grooming (P < 0.01) events were observed, even in inoculated animals in which not parasite eggs were found in faeces. During the first 28 days post-inoculation with H. contortus, feedlot performance was not affected (P = 0.16), but during the last 14 days (29-42) inoculated animals gained 15% less weight compared to controls (P = 0.04). Over 42 days, inoculated calves showed a 28% poorer feed efficiency during the 42 days post-inoculation than controls (P < 0.01). Across the experiment, calves inoculated with H. contortus obtained less net energy both for maintenance as for gain from diet (P < 0.01). It is concluded that both, performance and behaviour were modified in feedlot bull-calves parasitized by H. contortus, supporting the practice of deworming when eggs of this parasite are detected in the faeces even in low amounts.

Mexican Childhood Acute Lymphoblastic Leukemia: A Pilot Study of the MDR1 and MTHFR Gene Polymorphisms and Their Associations with Clinical Outcomes.

BACKGROUND: Genetic polymorphisms in patients with acute lymphoblastic leukemia (ALL) may influence the toxicity of chemotherapeutic agents. Due to the importance of the transport P-glycoprotein and methylenetetrahydrofolate reductase in the metabolism of chemotherapeutic agents, we analyzed the MDR1 rs1045642 and MTHFR rs1801133 polymorphisms and their associations with clinical outcomes in Mexican childhood ALL patients. METHODS: A total of 109 patients participated in this study. The clinical evaluation consisted of a physical examination and a laboratory test. Genotyping of MDR1 rs1045642 (3435 C>T) and MTHFR rs1801133 (677 C>T) was performed by polymerase chain reaction/restriction fragment length polymorphism. Statistical analyses were performed using SPSS 14.0. The odds ratios and 95% confidence intervals (CI) were estimated by logistic regression. RESULTS: Individuals who were CC homozygotes at MDR1 rs1045642 had lower risk of having methotrexate plasma concentrations >1 µM and leukopenia grade I (odds ratio [OR] = 0.30; 95% CI = 0.13-0.72 and OR = 0.32; 95% CI = 0.14-0.72, respectively). Patients who were CC homozygotes at MTHFR rs1801133 had a higher risk of developing mucositis (OR = 3.61; 95% CI = 1.42-9.14). CONCLUSION: MDR1 rs1045642 and MTHFR rs1801133 should be considered as diagnostic candidates for the identification of pediatric patients with a high risk of suffering adverse events during ALL treatment.